Lamivudine Stavudine & Nevirapine Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: Lamivudine 150 mg + Stavudine 30 or 40 mg + Nevirapine 200 mg
Reference Brands: Triomune®(Global)
Category: Anti Viral
Lamivudine, Stavudine & Nevirapine Tablets, often used in first-line HIV treatment, are available in 150/30/200 mg strength. Trusted brands like Triomune® offer affordable and effective ART. Via PharmaB2B, bulk procurement from WHO-GMP suppliers supports government tenders and HIV care programs in developing regions.
Product Description:
Lamivudine, Stavudine & Nevirapine Tablets are a fixed-dose antiretroviral combination widely used in the management of HIV-1 infection, particularly in first-line ART regimens in developing countries. Available in strengths like 150/30/200 mg, this combination ensures improved patient compliance and cost-effective therapy. Marketed under trusted names like Triomune®, the formulation is procured by governments, NGOs, and hospitals across Africa, Asia, and Latin America. Through PharmaB2B platforms, buyers can access high-quality, WHO-GMP-compliant products in bulk for tenders, institutional supply, and public health programs. It remains a vital component in scaling up global HIV treatment access.
Lamivudine Stavudine & Nevirapine — third party manufacturing & bulk supply
Lamivudine Stavudine & Nevirapine is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Lamivudine Stavudine & Nevirapine is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Lamivudine Stavudine & Nevirapine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Lamivudine Stavudine & Nevirapine →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Lamivudine, stavudine, and nevirapine are used together for the treatment of HIV-1 infection. This triple-drug therapy helps suppress viral replication, increase CD4 cell counts, and slow the progression of HIV. It is commonly used in resource-limited settings as part of combination antiretroviral therapy.
It is made from three active substances: Lamivudine, a nucleoside reverse transcriptase inhibitor (NRTI); Stavudine, another NRTI; and Nevirapine, a non-nucleoside reverse transcriptase inhibitor (NNRTI). Together, they block HIV replication at different stages.
Common trade names include
Triomune was originally manufactured by
The generic name is Lamivudine + Stavudine + Nevirapine.
The most recognized brand name is
It is manufactured in India by multiple approved pharmaceutical manufacturers, including Cipla and other licensed generic producers.
Related Products
Brincidofovir
Strength:
100 mg, 10 mg/ml
Form: Tablets / Oral suspension
Reference Brands: Tembexa (USA/EU)
View Details
Lenacapavir
Strength:
300 mg, 463.5 mg/1.5 mL
Form: Tablet / Injection
Reference Brands: Yeztugo (USA), Sunlenca (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
